Evidence map›Paper›PMID 24436329›Full record

ArticleThe Journal of biological chemistry2014

Conformational heterogeneity in antibody-protein antigen recognition: implications for high affinity protein complex formation.

Philip W Addis, Catherine J Hall, Shaun Bruton, Vaclav Veverka, Ian C Wilkinson, Frederick W Muskett, Philip S Renshaw, Christine E Prosser, Bruce Carrington, Alastair D G Lawson and 5 more

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Antibody cross-reactivity between casein and myelin-associated glycoprotein results in central nervous system demyelination.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  4. Article
  5. Article
  6. VProteins · 2020
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Philip W AddisDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom.
Catherine J HallDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom.
Shaun BrutonDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom.
Vaclav VeverkaDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom.
Ian C WilkinsonDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom.
Frederick W MuskettDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom.
Philip S RenshawDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom.
Christine E ProsserDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom; Research and Development, UCB, Slough SL1 3WE, United Kingdom.
Bruce CarringtonResearch and Development, UCB, Slough SL1 3WE, United Kingdom.
Alastair D G LawsonResearch and Development, UCB, Slough SL1 3WE, United Kingdom.
Robert GriffinResearch and Development, UCB, Slough SL1 3WE, United Kingdom.
Richard J TaylorResearch and Development, UCB, Slough SL1 3WE, United Kingdom.
Lorna C WatersDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom. Electronic address: lw83@le.ac.uk.
Alistair J HenryResearch and Development, UCB, Slough SL1 3WE, United Kingdom. Electronic address: alistair.henry@ucb.com.
Mark D CarrDepartment of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom. Electronic address: mdc12@le.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Specific, high affinity protein-protein interactions lie at the heart of many essential biological processes, including the recognition of an apparently limitless range of foreign proteins by natural antibodies, which has been exploited to develop therapeutic antibodies. To mediate biological processes, high affinity protein complexes need to form on appropriate, relatively rapid timescales, which presents a challenge for the productive engagement of complexes with large and complex contact surfaces (∼600-1800 Å(2)). We have obtained comprehensive backbone NMR assignments for two distinct, high affinity antibody fragments (single chain variable and antigen-binding (Fab) fragments), which recognize the structurally diverse cytokines interleukin-1β (IL-1β, β-sheet) and interleukin-6 (IL-6, α-helical). NMR studies have revealed that the hearts of the antigen binding sites in both free anti-IL-1β Fab and anti-IL-6 single chain variable exist in multiple conformations, which interconvert on a timescale comparable with the rates of antibody-antigen complex formation. In addition, we have identified a conserved antigen binding-induced change in the orientation of the two variable domains. The observed conformational heterogeneity and slow dynamics at protein antigen binding sites appears to be a conserved feature of many high affinity protein-protein interfaces structurally characterized by NMR, suggesting an essential role in protein complex formation. We propose that this behavior may reflect a soft capture, protein-protein docking mechanism, facilitating formation of high affinity protein complexes on a timescale consistent with biological processes.

Indexed as

Antibody AffinityAmino Acid SequenceAntibodies, Monoclonal, HumanizedAntigen-Antibody ComplexAntigensHumansImmunoglobulin Fab FragmentsInterleukin-1betaInterleukin-6Molecular Sequence DataNuclear Magnetic Resonance, BiomolecularProtein Structure, SecondaryAntibodies, Monoclonal, HumanizedAntigen-Antibody ComplexAntigensImmunoglobulin Fab FragmentsInterleukin-1betaInterleukin-6AntibodiesCDRConformational HeterogeneityNMRProtein ConformationProtein-Protein InteractionsProtein Structure

Identifiers

PMID24436329
PMCPMC3945379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.